25 May 2013
Keywords: GlaxoSmithKline, Human Genome Sciences, Benlysta, FDA, PDUFA, Lupus
Article | 06 December 2010
UK pharmaceutical giant GlaxoSmithKline (LSE: GSK) and the USA’s Human Genome Sciences (Nasdaq: HGSI) revealed on Friday that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 December 2010
24 May 2013
© 2013 thepharmaletter.com